Search

Search Constraints

You searched for: Author/Creator Traboulsee, Anthony

Search Results

1. 060 Association of brain volume loss and neda outcomes in patients with relapsing multiple sclerosis in the opera i and opera ii studies (ENCORE). Issue 6 (24th May 2018)

2. 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Issue 8 (August 2021)

4. Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. (12th September 2017)

5. Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. (12th September 2017)

6. Anisotropic cerebral vascular architecture causes orientation dependency in cerebral blood flow and volume measured with dynamic susceptibility contrast magnetic resonance imaging. Issue 3 (March 2017)

7. Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case–control study protocol for dimethyl fumarate-induced lymphopenia. Issue 5 (2nd June 2017)

9. Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data. (April 2022)

10. Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring. (21st April 2015)